Company Filing History:
Years Active: 2016-2020
Title: Alice Banz: Pioneering Innovations in Anti-Tumor Vaccines
Introduction
Alice Banz, an accomplished inventor based in Lyons, France, has made significant contributions to the field of immunotherapy, particularly in the development of anti-tumor vaccines. With a total of three patents to her name, Banz is dedicated to advancing medical treatments that harness the body's immune response against cancer cells.
Latest Patents
Among her latest innovations is an inventive composition designed to induce a cytotoxic cell response in a host, specifically targeting cells that express tumor-associated antigens. This innovative composition incorporates red blood cells containing the relevant antigen and may be adjusted through techniques such as forming immune complexes with immunoglobulin, particularly IgG, or through heat or chemical treatments to enhance phagocytosis by dendritic cells. Additionally, her patent includes a variant utilizing xenogenic red blood cells, all aimed at creating an effective therapeutic anti-tumor vaccine.
Career Highlights
Alice Banz currently works at Erytech Pharma, a biotechnology company specializing in innovative treatments for cancer and rare diseases. Her role at Erytech signifies her commitment to bridging the gap between research and practical therapeutic applications, fostering advancements in the pharmaceutical field.
Collaborations
In her professional journey, Alice collaborates with talented peers, including Yann Godfrin, contributing to a shared vision of developing groundbreaking solutions to combat cancer. These collaborations enhance the creative and scientific processes involved in creating effective therapeutic strategies.
Conclusion
Alice Banz exemplifies the spirit of innovation in the medical field, with her work paving the way for new therapies in cancer treatment. Her continued research and patent developments not only reflect her commitment to improving health outcomes but also highlight the vital role that inventors play in transforming scientific discoveries into actionable medical solutions.